Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Tablets × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other 1 Gynecologic 1 Gastrointestinal 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 17 Triple Negative Breast Neoplasms 2 Cardiotoxicity 2 Obesity 1 Inflammation 1 Hot Flashes 1 Genetic Diseases, Inborn 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Advanced Breast Cancer 1

Interventions

palbociclib 2 Ketorolac 2 dapagliflozin 1 Tablets 1 Surgical Procedures, Operative 1 Sulindac 1 Specimen Handling 1 Rivaroxaban 1 Resistance Training 1 Radiotherapy, Conformal 1 Pregabalin 1 Plastic Surgery Procedures 1 Omeprazole 1 Neoadjuvant Therapy 1 Mastectomy 1 Massage 1 Losartan 1 Ibuprofen 1 Fish Oils 1 Exercise 1 Cognitive Behavioral Therapy 1 Bevacizumab 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡